Overview
ELAN market data
Price History
ELAN price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.47 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.69 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -4.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $17.11 – $27.98 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $11.3B · P/B 1.72 · P/S 2.24.
Company News
Reported Earlier, FDA Issues Issues Emergency Use Authorization For Elanco's CLiK Extra Wound Spray For Prevention Of New World Screwworm InfestationsBenzinga · Aug 7, 2026, 1:25 PM
UBS Maintains Buy on Elanco Animal Health, Raises Price Target to $33Benzinga · Aug 6, 2026, 7:21 PM
Keybanc Maintains Overweight on Elanco Animal Health, Raises Price Target to $30Benzinga · Aug 6, 2026, 2:21 PM
Elanco Sees Strong Pet Health Momentum, Bets on Innovative ProductsBenzinga · Aug 5, 2026, 4:57 PM
Wynn Resorts Posts Upbeat Q2 Earnings, Joins Bloomin' Brands, Shopify, Owens Corning And Other Big Stocks Moving Higher On WednesdayBenzinga · Aug 5, 2026, 2:01 PM
Elanco Animal Health shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance above estimates. Also, the company issued Q3 sales guidance above estimates.Benzinga · Aug 5, 2026, 11:33 AM
Elanco Animal Health Sees Q3 Adj EPS $0.19-$0.22 vs $0.20 Est; Sees Sales $1.195B-$1.220B vs $1.192B EstBenzinga · Aug 5, 2026, 10:29 AM
Elanco Animal Health Raises FY2026 Adj EPS Guidance from $1.03-$1.09 to $1.10-$1.16 vs $1.09 Est; Raises FY2026 Sales Guidance from $5.010B-$5.085B to $5.090B-$5.140B vs $5.062B EstBenzinga · Aug 5, 2026, 10:29 AM
Elanco Animal Health Q2 Adj. EPS $0.34 Beats $0.27 Estimate, Sales $1.368B Beat $1.313B EstimateBenzinga · Aug 5, 2026, 10:28 AM
8-K filing — Elanco Animal Health Inc (ELAN)SEC EDGAR · Aug 5, 2026, 10:27 AM